Company Filing History:
Years Active: 2017
Title: Pasquale Pierimarchi: Innovator in Pharmaceutical Preparations
Introduction
Pasquale Pierimarchi is a notable inventor based in Abano Terme, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for neoplasias. His work focuses on the therapeutic use of bioconjugates that enhance the efficacy of antitumoral drugs.
Latest Patents
Pasquale Pierimarchi holds a patent for the "Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias." This invention describes a novel application in oncology, utilizing bioconjugates formed by conjugating hyaluronic acid with chemotherapeutic agents such as Irinotecan, Doxorubicin, Paclitaxel, Cis-platinum, and 5-Fluorouracyl (5-FU). The patent highlights the biological behavior, action mechanisms, efficacy, and tolerability of these pharmaceutical preparations, particularly focusing on ONCOFID-S and ONCOFID-D formulations.
Career Highlights
Pasquale Pierimarchi is associated with Fidia Farmaceutici S.p.a., where he has been instrumental in advancing pharmaceutical research and development. His innovative approach has led to significant advancements in cancer treatment methodologies.
Collaborations
He has collaborated with notable colleagues, including Monica Campisi and Davide Renier, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.
Conclusion
Pasquale Pierimarchi's work exemplifies the intersection of innovation and healthcare, showcasing how targeted pharmaceutical preparations can revolutionize cancer treatment. His contributions continue to impact the field positively.